Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azithramycine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Bermudez LE et al. | Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells. | 1994 | Antimicrob. Agents Chemother. | pmid:8067766 |
Uzun O et al. | Efficacy of a three-day course of azithromycin in the treatment of community-acquired pneumococcal pneumonia. Preliminary report. | 1994 | J Chemother | pmid:8071680 |
Lang R et al. | Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis. | 1994 Jul-Aug | Chemotherapy | pmid:8082413 |
Eisenberg E and Barza M | Azithromycin and clarithromycin. | 1994 | Curr Clin Top Infect Dis | pmid:8086122 |
Wynn RF et al. | Azithromycin for cerebral toxoplasmosis in AIDS. | 1993 | Lancet | pmid:8093526 |
Bailey RL et al. | Randomised controlled trial of single-dose azithromycin in treatment of trachoma. | 1993 | Lancet | pmid:8102427 |
Parent M | [Initial empiric treatment of pneumonia and the new antibiotics]. | 1994 | Union Med Can | pmid:8109061 |
Saba J et al. | Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS. | 1993 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8112357 |
Rodriguez WJ and Wiedermann BL | The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections. | 1994 | Adv Pediatr Infect Dis | pmid:8123221 |
Kanatani MS and Guglielmo BJ | The new macrolides. Azithromycin and clarithromycin. | 1994 | West. J. Med. | pmid:8128699 |
Weber K et al. | Azithromycin versus penicillin V for the treatment of early Lyme borreliosis. | 1993 Nov-Dec | Infection | pmid:8132365 |
DÃaz Sánchez M et al. | [New medications: azithromycin]. | 1993 Jul-Sep | Rev Med Univ Navarra | pmid:8134755 |
SteingrÃmsson O et al. | Single dose azithromycin treatment of gonorrhea and infections caused by C. trachomatis and U. urealyticum in men. | 1994 Jan-Feb | Sex Transm Dis | pmid:8140488 |
Pfefferkorn ER and Borotz SE | Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin. | 1994 | Antimicrob. Agents Chemother. | pmid:8141576 |
Bermudez LE et al. | Recombinant granulocyte-macrophage colony-stimulating factor enhances the effects of antibiotics against Mycobacterium avium complex infection in the beige mouse model. | 1994 | J. Infect. Dis. | pmid:8158029 |
Bosatra A et al. | [Effectiveness of and tolerance to azithromycin versus roxithromycin in the treatment of patients with acute infections of the upper respiratory tract]. | 1994 | Clin Ter | pmid:8168348 |
Kelsey JJ et al. | Presence of azithromycin breast milk concentrations: a case report. | 1994 | Am. J. Obstet. Gynecol. | pmid:8178871 |
Spangler SK et al. | Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. | 1994 | Antimicrob. Agents Chemother. | pmid:8192445 |
Stamler DA et al. | Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. | 1994 | Antimicrob. Agents Chemother. | pmid:8192446 |
Mizukane R et al. | Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. | 1994 | Antimicrob. Agents Chemother. | pmid:8203850 |
Marchi M et al. | [Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori]. | 1994 | Minerva Gastroenterol Dietol | pmid:8204705 |
Benson CA | Treatment of disseminated disease due to the Mycobacterium avium complex in patients with AIDS. | 1994 | Clin. Infect. Dis. | pmid:8204776 |
Blais J et al. | Inhibition of Toxoplasma gondii protein synthesis by azithromycin. | 1993 | Antimicrob. Agents Chemother. | pmid:8215287 |
Dever LL et al. | Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. | 1993 | Antimicrob. Agents Chemother. | pmid:8215288 |
Scaglione F et al. | A new model examining intracellular and extracellular activity of amoxicillin, azithromycin, and clarithromycin in infected cells. | 1993 Nov-Dec | Chemotherapy | pmid:8222870 |
Braga PC and Piatti G | Interference by subinhibitory concentrations of azithromycin with the mechanism of bacterial adhesion to human epithelial cells. | 1993 Nov-Dec | Chemotherapy | pmid:8222872 |
Weiss LM et al. | Efficacy of azithromycin for treating Babesia microti infection in the hamster model. | 1993 | J. Infect. Dis. | pmid:8228366 |
Lefèvre JC et al. | In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis. | 1993 | Pathol. Biol. | pmid:8233628 |
Agacfidan A et al. | In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae. | 1993 | Antimicrob. Agents Chemother. | pmid:8239579 |
Tomazic J et al. | In vivo administration of azithromycin affects lymphocyte activity in vitro. | 1993 | Antimicrob. Agents Chemother. | pmid:8239585 |
Cantin L and Chamberland S | In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii. | 1993 | Antimicrob. Agents Chemother. | pmid:8239619 |
Fass RJ | Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. | 1993 | Antimicrob. Agents Chemother. | pmid:8257127 |
de Górgolas Hernández-Mora M et al. | [Therapeutic approaches to cryptosporidiosis. A review of the literature]. | 1993 | Rev Clin Esp | pmid:8259458 |
Saverino D et al. | Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. | 1993 | New Microbiol. | pmid:8264424 |
Pajukanta R | In vitro antimicrobial susceptibility of Porphyromonas gingivalis to azithromycin, a novel macrolide. | 1993 | Oral Microbiol. Immunol. | pmid:8265209 |
Gage TW | New drugs from 1991-1992. | 1993 | Tex Dent J | pmid:8273018 |
Donowitz GR and Earnhardt KI | Azithromycin inhibition of intracellular Legionella micdadei. | 1993 | Antimicrob. Agents Chemother. | pmid:8285604 |
Meyer AP et al. | Uptake of azithromycin by human monocytes and enhanced intracellular antibacterial activity against Staphylococcus aureus. | 1993 | Antimicrob. Agents Chemother. | pmid:8285612 |
Lalak NJ and Morris DL | Azithromycin clinical pharmacokinetics. | 1993 | Clin Pharmacokinet | pmid:8287632 |
Godofsky EW | Treatment of presumed cerebral toxoplasmosis with azithromycin. | 1994 | N. Engl. J. Med. | pmid:8302335 |
O'Connell S et al. | Chronic active toxoplasmosis in an immunocompetent patient. | 1993 | J. Infect. | pmid:8308325 |
Berger BW | Lyme disease. | 1993 | Semin Dermatol | pmid:8312152 |
Odugbemi T et al. | Single oral dose of azithromycin for therapy of susceptible sexually transmitted diseases: a multicenter open evaluation. | 1993 Jul-Sep | West Afr J Med | pmid:8312208 |
Holdcroft C | Two new macrolide antibiotics: clarithromycin and azithromycin. | 1993 | Nurse Pract | pmid:8380492 |
Spangler SK and Appelbaum PC | Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2. | 1993 | J. Clin. Microbiol. | pmid:8381817 |
Nahata MC et al. | Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. | 1993 | Antimicrob. Agents Chemother. | pmid:8383944 |
Vaara M | Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria. | 1993 | Antimicrob. Agents Chemother. | pmid:8383945 |
Brown ST et al. | Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine. | 1993 | Antimicrob. Agents Chemother. | pmid:8384809 |
Cameron DJ | Effectiveness of early Lyme disease treatment. | 1993 | Am. J. Med. | pmid:8388627 |
Hammerschlag MR et al. | Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. | 1993 | J. Pediatr. | pmid:8388950 |
Melski JW et al. | Primary and secondary erythema migrans in central Wisconsin. | 1993 | Arch Dermatol | pmid:8389536 |
Minguez F et al. | In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria. | 1993 May-Jun | Chemotherapy | pmid:8389685 |
Bonnet M and Van der Auwera P | Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence. | 1993 | Antimicrob. Agents Chemother. | pmid:8390808 |
Gordillo ME et al. | In vitro activity of azithromycin against bacterial enteric pathogens. | 1993 | Antimicrob. Agents Chemother. | pmid:8390813 |
Rodewald LE and Pichichero ME | Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports. | 1993 | J. Pediatr. | pmid:8391566 |
Vargas SL et al. | Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer. | 1993 | J. Pediatr. | pmid:8391567 |
Gingras BA and Jensen JB | Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei. | 1993 | Am. J. Trop. Med. Hyg. | pmid:8394660 |
Mansoor GA et al. | Azithromycin-induced acute interstitial nephritis. | 1993 | Ann. Intern. Med. | pmid:8395778 |
Guerra LG et al. | Rapid response of AIDS-related bacillary angiomatosis to azithromycin. | 1993 | Clin. Infect. Dis. | pmid:8399879 |
Goldman MP and Longworth DL | The role of azithromycin and clarithromycin in clinical practice. | 1993 Sep-Oct | Cleve Clin J Med | pmid:8403355 |
Fortner JH et al. | Tapetal effect of an azalide antibiotic following oral administration in beagle dogs. | 1993 | Fundam Appl Toxicol | pmid:8405779 |
Narcio Reyes LE et al. | [Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections]. | 1993 | Ginecol Obstet Mex | pmid:8406112 |
Kobrehel G et al. | 9a,11-cyclic carbamates of 15-membered azalides. | 1993 | J. Antibiot. | pmid:8407586 |
Workowski KA et al. | Azithromycin in chlamydial urethritis. | 1993 | JAMA | pmid:8411548 |
Genç M et al. | An economic evaluation of screening for Chlamydia trachomatis in adolescent males. | 1993 | JAMA | pmid:8411572 |
Kuschner RA et al. | Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent. | 1995 | Clin. Infect. Dis. | pmid:8527539 |
Erdogru T et al. | The treatment of non-gonococcal urethritis with single dose oral azithromycin. | 1995 Sep-Oct | J. Int. Med. Res. | pmid:8529783 |
Kieserman SP et al. | Streptococcal pharyngitis: alternative treatments. | 1995 | Ear Nose Throat J | pmid:8536567 |
van Rijsoort-Vos JH et al. | In-vitro activity of a new quinolone (CP-99,219) compared with ciprofloxacin, pefloxacin, azithromycin and penicillin against Neisseria gonorrhoeae. | 1995 | J. Antimicrob. Chemother. | pmid:8537268 |
Carbon C | [Azithromycin: from macrolides to azalides]. | 1995 | Pathol. Biol. | pmid:8539067 |
[Special issue devoted to azithromycin]. | 1995 | Pathol. Biol. | pmid:8539068 | |
Bergogne-Bérézin E | [Azithromycin: tissue pharmacology]. | 1995 | Pathol. Biol. | pmid:8539071 |
Singlas E | [Clinical pharmacokinetics of azithromycin]. | 1995 | Pathol. Biol. | pmid:8539072 |
Felstead S | Azithromycin drug interactions. | 1995 | Pathol. Biol. | pmid:8539073 |
Modaï J | [Azithromycin: clinical assessment]. | 1995 | Pathol. Biol. | pmid:8539076 |
Gehanno P | [Use of azithromycin in ORL]. | 1995 | Pathol. Biol. | pmid:8539077 |
Leophonte P | [Azithromycin and bronchopulmonary infections]. | 1995 | Pathol. Biol. | pmid:8539078 |
Micoud M and Pépin LF | [Azithromycin and genital infections]. | 1995 | Pathol. Biol. | pmid:8539079 |
Coulaud JP | [Azithromycin: new orientations]. | 1995 | Pathol. Biol. | pmid:8539080 |
Reinert P | [Effects of azithromycin on the virulence of Pseudomonas aeruginosa]. | 1995 | Pathol. Biol. | pmid:8539081 |
Mégraud F et al. | [Helicobacter pylori and azithromycin]. | 1995 | Pathol. Biol. | pmid:8539082 |
Derouin F | [New pathogens and mode of action of azithromycin: Toxoplasma gondii]. | 1995 | Pathol. Biol. | pmid:8539083 |
Perronne C | [Azithromycin and Mycobacterium avium infection]. | 1995 | Pathol. Biol. | pmid:8539084 |
Edelstein PH | Review of azithromycin activity against Legionella spp. | 1995 | Pathol. Biol. | pmid:8539085 |
Tissi L et al. | In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. | 1995 | Antimicrob. Agents Chemother. | pmid:8540695 |
Oh YK et al. | Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. | 1995 | Antimicrob. Agents Chemother. | pmid:8540724 |
Amsden GW | Macrolides versus azalides: a drug interaction update. | 1995 | Ann Pharmacother | pmid:8547740 |
Magid D et al. | Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. | 1996 | Ann. Intern. Med. | pmid:8554247 |
Bauernfeind A et al. | Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens. | 1995 Sep-Oct | Infection | pmid:8557398 |
Clancy J et al. | Assays to detect and characterize synthetic agents that inhibit the ErmC methyltransferase. | 1995 | J. Antibiot. | pmid:8557568 |
Martin DH et al. | Comparison of azithromycin and ceftriaxone for the treatment of chancroid. | 1995 | Clin. Infect. Dis. | pmid:8562752 |
Amin NM and Breadon G | An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. | 1995 Jul-Aug | Clin Ther | pmid:8565033 |
Principi N | Multicentre comparative study of the efficacy and safety of azithromycin compared with amoxicillin/clavulanic acid in the treatment of paediatric patients with otitis media. | 1995 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8565983 |
Strickman D et al. | In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. | 1995 | Antimicrob. Agents Chemother. | pmid:8585717 |
Kuzman I et al. | Azithromycin for treatment of community acquired pneumonia caused by Legionella pneumophila: a retrospective study. | 1995 | Scand. J. Infect. Dis. | pmid:8588143 |
Bermudez LE et al. | Efficacy of azithromycin and rifabutin in preventing infection by Mycobacterium avium complex in beige mice. | 1995 | J. Antimicrob. Chemother. | pmid:8591938 |
Domingo S et al. | Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. | 1995 | J. Antimicrob. Chemother. | pmid:8591939 |
Nash KA and Inderlied CB | Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. | 1995 | Antimicrob. Agents Chemother. | pmid:8592991 |
Bohte R et al. | Levels of azithromycin and alpha-1 acid glycoprotein in serum in patients with community-acquired pneumonia. | 1995 | Antimicrob. Agents Chemother. | pmid:8593024 |
Bertoni G et al. | Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori: a controlled trial versus omeprazole plus amoxicillin. | 1996 | Am. J. Gastroenterol. | pmid:8607489 |